40 articles from SATURDAY 2.5.2020

Remdesivir: US allows emergency use of experimental drug for coronavirus

FDA says drug, which appears to help some recover faster, would be available for hospitalized Covid-19 patientsCoronavirus – latest US updatesCoronavirus – latest global updatesSee all our coronavirus coverageUS regulators have allowed the emergency use of the experimental drug remdesivir, which appears to help some coronavirus patients recover faster.It is the first drug shown to help fight...

Will coronavirus spell an end to the great Chinese buffet?

Designated serving spoons, no double-dipping and individual portions have all been floated as part of a new need for safetyCoronavirus – latest updatesSee all our coronavirus coverageIt is hard to imagine the body-blow of the “dining table revolution”, which the Chinese government is now encouraging as a means to hold down Covid-19 infection rates by reducing general physical...

Virgin Galactic’s SpaceShipTwo makes its first gliding test flight over New Mexico

For the first time, Virgin Galactic's SpaceShipTwo rocket plane flew free in the skies over New Mexico's Spaceport America, its new base of operations. The SpaceShipTwo plane, known as VSS Unity, has made rocket-powered flights beyond the 50-mile space milestone during tests at California's Mojave Air and Space Port, but today's unpowered test flight was the first to be flown from...

Antibodies from llamas could help in fight against COVID-19, study suggests

Researchers linked two copies of a special kind of antibody produced by llamas to create a new antibody that binds tightly to a key protein on the coronavirus that causes COVID-19. This protein, called the spike protein, allows the virus to break into host cells. Initial tests indicate that the antibody blocks viruses that display this spike protein from infecting cells in culture.

Hydroxychloroquine linked to increased risk of cardiac arrhythmias

In a new report, a team of pharmacists and clinicians found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at increased risk of electrical changes to the heart and cardiac arrhythmias. The combination of hydroxychloroquine with azithromycin was linked to even greater changes compared to hydroxychloroquine alone.